Cargando…

RAS screening in colorectal cancer: a comprehensive analysis of the results from the UK NEQAS colorectal cancer external quality assurance schemes (2009–2016)

Evidence strongly indicates that extended RAS testing should be undertaken in mCRC patients, prior to prescribing anti-EGFR therapies. With more laboratories implementing testing, the requirement for External Quality Assurance schemes increases, thus ensuring high standards of molecular analysis. Da...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richman, Susan D., Fairley, Jennifer, Butler, Rachel, Deans, Zandra C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711992/ https://www.ncbi.nlm.nih.gov/pubmed/28653203 http://dx.doi.org/10.1007/s00428-017-2162-7

Ejemplares similares

How close are we to standardised extended RAS gene mutation testing? The UK NEQAS evaluation
por: Richman, Susan D, et al.
Publicado: (2017)

Results of the UK NEQAS for Molecular Genetics reference sample analysis
por: Richman, Susan D, et al.
Publicado: (2018)

The history and evolution of HLA typing external proficiency testing schemes in UK NEQAS for H&I
por: De’Ath, A., et al.
Publicado: (2023)

Development of a United Kingdom National External Quality Assessment Scheme (UK NEQAS) for HIV point of care testing
por: Abdul-Khaliq, Catherine
Publicado: (2011)

International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA
por: Keppens, Cleo, et al.
Publicado: (2018)

UK NEQAS ICC & ISH Ki-67 Data Reveal Differences in Performance of Primary Antibody Clones
por: Parry, Suzanne, et al.
Publicado: (2021)

External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot scheme
por: Esposito Abate, Riziero, et al.
Publicado: (2022)

Correction to: External quality assessment (EQA) for tumor mutational burden: results of an international IQN path feasibility pilot scheme
por: Esposito Abate, Riziero, et al.
Publicado: (2022)

Interpretation in Clinical Biochemistry: An External Quality Assurance Scheme
por: Challand, Gordon, et al.
Publicado: (2004)

Targeting BRAF and RAS in Colorectal Cancer
por: Bellio, Helene, et al.
Publicado: (2021)

Ensuring high standards for the delivery of NIPT world‐wide: Development of an international external quality assessment scheme
por: Deans, Zandra C., et al.
Publicado: (2019)

Results of a worldwide external quality assessment of cfDNA testing in lung Cancer
por: Fairley, Jennifer A., et al.
Publicado: (2022)

External validation of risk prediction models for incident colorectal cancer using UK Biobank
por: Usher-Smith, J A, et al.
Publicado: (2018)

RAS testing in metastatic colorectal cancer: advances in Europe
por: Van Krieken, J Han JM, et al.
Publicado: (2015)

Detection of Mutant RAS Subpopulations in Colorectal Cancer Patients
por: Banda, Malathi
Publicado: (2015)

RAS, Cellular Plasticity, and Tumor Budding in Colorectal Cancer
por: Maffeis, Valeria, et al.
Publicado: (2019)

Strategies to tackle RAS-mutated metastatic colorectal cancer
por: Patelli, G., et al.
Publicado: (2021)

The impact of RAS mutation on the treatment strategy of colorectal cancer
por: Pirvu, Edvina Elena, et al.
Publicado: (2023)

Implementation of the updated NICE haematological cancers (NG47) improving outcomes guidelines across Specialist Integrated Haematological Malignancy Diagnostic Services (SIHMDS) in England: a UK NEQAS LI survey
por: Cartwright, Ashley, et al.
Publicado: (2023)

Monitoring of RAS mutant clones in plasma of patients with RAS mutant metastatic colorectal cancer
por: Fernández Montes, A., et al.
Publicado: (2022)

Quality assurance in pathology in colorectal cancer screening and diagnosis—European recommendations
por: Quirke, Phil, et al.
Publicado: (2010)

Correction: External validation of risk prediction models for incident colorectal cancer using UK Biobank
por: Usher-Smith, J. A., et al.
Publicado: (2020)

Ha-ras restriction fragment length polymorphisms in colorectal cancer.
por: Wyllie, F. S., et al.
Publicado: (1988)

Fast simultaneous detection of K-RAS mutations in colorectal cancer
por: Chang, Ya-Sian, et al.
Publicado: (2009)

Spectrum of K ras mutations in Pakistani colorectal cancer patients
por: Murtaza, B.N., et al.
Publicado: (2013)

Comparison of K-ras mutations in lung, colorectal and gastric cancer
por: PENG, NANQIU, et al.
Publicado: (2014)

Panitumumab in Metastatic Colorectal Cancer: The Importance of Tumour RAS Status
por: Peeters, Marc, et al.
Publicado: (2015)

Controversies in the treatment of RAS wild-type metastatic colorectal cancer
por: Vera, R., et al.
Publicado: (2020)

Annex to Quirke et al. Quality assurance in pathology in colorectal cancer screening and diagnosis: annotations of colorectal lesions
por: Vieth, Michael, et al.
Publicado: (2010)

Prognosis of colorectal cancer patients is associated with the novel log odds of positive lymph nodes scheme: derivation and external validation
por: Zhang, Qing-Wei, et al.
Publicado: (2020)

The CDC Colorectal Cancer Control Program, 2009–2015
por: Joseph, Djenaba A., et al.
Publicado: (2019)

Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study
por: Andreyev, H J N, et al.
Publicado: (2001)

High Intra- and Inter-Tumoral Heterogeneity of RAS Mutations in Colorectal Cancer
por: Jeantet, Marion, et al.
Publicado: (2016)

Perspectives in the Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer Patients
por: Rosati, Gerardo, et al.
Publicado: (2021)

Occurence of RAS reversion in metastatic colorectal cancer patients treated with bevacizumab
por: Epistolio, Samantha, et al.
Publicado: (2021)

Therapeutic impact of determination of RAS mutations in the plasma of patient with colorectal cancer
por: Macedo, F, et al.
Publicado: (2022)

A new model of time scheme for progression of colorectal cancer
por: Sun, Shuhao, et al.
Publicado: (2014)

Complications as indicators of quality assurance after 401 consecutive colorectal cancer resections: the importance of surgeon volume in developing colorectal cancer units in India
por: Shetty, Guruprasad S, et al.
Publicado: (2012)

Impact of implementing a category 1 external quality assurance scheme for monitoring harmonization of clinical laboratories in Spain
por: Ricós, Carmen, et al.
Publicado: (2020)

Increasing Trend of Colorectal Cancer Incidence in Korea, 1999-2009
por: Shin, Aesun, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_38jh8s3sks5qaoj9sd001mm4gn